Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Since 2022, the U.S. Food and Drug Administration has been actively urging consumers to avoid purchasing or consuming tianeptine -- a synthetic drug commonly called "gas station heroin" that can mimic the actions of opioids like fentanyl. Now, the FDA is upping the urgency of it's warnings as vendors continue to market the drug as a so-called "dietary supplement." UConn's C. Michael White, a Distinguished Professor of Pharmacy Practice, spoke with The Conversation about the problem with tianeptine in a must-read Q-and-A: What is tianeptine and why is it risky? Tianeptine stimulates the same receptors as well-known opioids such as fentanyl, heroin and morphine. When these drugs make their way from the blood to the brain, they bind to the “mu” type opioid receptor that triggers the sought-after pain relief and euphoria of those drugs as well as the dangerous effects like slowed or stopped breathing. High doses of tianeptine can bring euphoric effects similar to heroin and can also bring about the dissociative effect – the perception of your mind being disconnected from your surroundings and body – that is reminiscent of ketamine, an anesthetic that has a role in treating post-traumatic stress disorder and depression but has also commonly been abused as a street drug. Products containing tianeptine are often called “legal high drugs” – sometimes dubbed “gas station drugs” – a term used for all non-FDA-approved synthetic drugs that are sold casually in gas stations, online and elsewhere. What are the major adverse effects that people can experience? Data from clinical trials, case reports and poison control centers shows that tianeptine commonly induces agitation. This is typically accompanied by a fast heart rate and high blood pressure, confusion, nightmares, drowsiness, dry mouth and nausea, among other conditions. The most serious adverse events are slowed or stopped breathing, coma, heart arrhythmia and death. When long-term users try to stop tianeptine use, they often experience withdrawal symptoms reminiscent of opioid withdrawal. Consumers need to be aware that products containing tianeptine may not adhere to good manufacturing practices. This means they could contain lead or have other heavy metal contamination or be contaminated by microorganisms such as salmonella or mold. They could also contain other drug ingredients that are not disclosed. Knowingly or unknowingly combining active ingredients can increase the risk of adverse events. Additionally, the amount of the active ingredient contained in the product can vary widely, even with the same manufacturer. So past use does not guarantee that using the same amount will provide the same effect. How are these drugs sold in the US if they are not FDA-approved? If a drug product is not FDA-approved for prescription or over-the-counter-use, it is the Drug Enforcement Agency that is responsible for controlling market access. Before the DEA can ban an active ingredient in a drug product, it must be designated Schedule I, meaning the drug has no legitimate medical purpose and has high abuse potential. Manufacturers do not have to alert the DEA before selling their products to U.S. citizens. This means the DEA must detect an issue, identify the products causing the issue, identify the active ingredients in the product in question and do a full scientific review before designating it as Schedule I. Tianeptine came to market masquerading as a dietary supplement in gas stations and smoke shops, even though it is a synthetic compound. Tianeptine is also sold online allegedly for research purposes and not for human consumption. Tianeptine is undergoing clinical trials for the treatment of pain and depression, but sellers do nothing to make this type of labeling clear to consumers or to restrict purchases to researchers. What can people do to protect themselves and their families? Non-FDA-approved products containing synthetic drugs are very risky to use and should be avoided. FDA-approved drugs are available by a prescription from a health professional or over the counter with active ingredients on an approved list. If someone in a gas station, smoke shop or over the internet touts the benefits of a non-FDA-approved drug product – for pain or anxiety relief, to increase energy or for a buzz – be aware. It could be dangerous the first time you use it, but using it successfully once also doesn’t mean the experience will be the same the next time, and continued use can cause addiction. If a product is being sold “not for human consumption” or “for research purposes only,” you are at a high risk if you take it. Before you take any dietary supplement, make sure you check the active ingredient to be sure that it is, in fact, a natural product and not a synthetic chemical. If someone you know has bags with unmarked powder, a product labeled for research use or not for human consumption, or tablets or capsules not in standard drug bottles, that is a sign of a potentially dangerous situation. Standard drug tests sold over the counter are not designed to pick up tianeptine. One of the main reasons that people use these alternative substances of abuse over regular opioids, cannabis or amphetamines is that they are much harder to detect through work- or at-home drug screens by parents, schools, employers, probation officers and so on. If the DEA is not responding to emerging threats quickly enough, individual states can also act to ban sales of dangerous active ingredients in products. As of January 2024, at least 12 states have banned the sale of tianeptine, according to the FDA, although people in those states can still illegally procure it from the internet. So contacting your state legislators could be a place to start exercising your power to help prevent the harms from these products. This is an important piece, and if you are looking to know about tianeptine and the threat it poses to consumers in America, then let us help. Dr. C. Michael White is an expert in the areas of comparative effectiveness and preventing adverse events from drugs, devices, dietary supplements, and illicit substances. Dr. White is available to speak with media -- click on his icon now to arrange an interview today.
Research: Add space salad to the risks astronauts face
University of Delaware researchers grew lettuce under conditions that imitated the weightless environment aboard the International Space Station and found those plants were actually more prone to infections from Salmonella. It’s been more than three years since the National Aeronautics and Space Administration made space-grown lettuce an item on the menu for astronauts aboard the International Space Station. Alongside their space diet staples of flour tortillas and powdered coffee, astronauts can munch on a salad, grown from control chambers aboard the ISS that account for the ideal temperature, amount of water and light that plants need to mature. But as the UD researchers discovered, there is a problem. The International Space Station has a lot of pathogenic bacteria and fungi. Many of these disease-causing microbes at the ISS are very aggressive and can easily colonize the tissue of lettuce and other plants. Once people eat lettuce that’s been overrun by E. coli or Salmonella, they can get sick. With billions of dollars poured into space exploration each year by NASA and private companies like SpaceX, some researchers are concerned that a foodborne illness outbreak aboard the International Space Station could derail a mission. In the new study by UD's team, published in Scientific Reports and in npj Microgravity, researchers grew lettuce in a weightless environment similar to that found at the International Space Station. Plants are masters of sensing gravity, and they use roots to find it. The plants grown at UD were exposed to simulated microgravity by rotation. The researchers found those plants under the manufactured microgravity were actually more prone to infections from Salmonella, a human pathogen. Stomata, the tiny pores in leaves and stems that plants use to breathe, normally close to defend a plant when it senses a stressor, like bacteria, nearby, said Noah Totsline, an alumnus of UD’s Department of Plant and Soil Sciences who finished his graduate program in December. When the researchers added bacteria to lettuce under their microgravity simulation, they found the leafy greens opened their stomata wide instead of closing them. “The fact that they were remaining open when we were presenting them with what would appear to be a stress was really unexpected,” Totsline said. Totsline, the lead author of both papers, worked with plant biology professor Harsh Bais as well as microbial food safety professor Kali Kniel and Chandran Sabanayagam of the Delaware Biotechnology Institute. The research team used a device called a clinostat to rotate plants at the speed of a rotisserie chicken on a spinner. “In effect, the plant would not know which way was up or down,” Totsline said. “We were kind of confusing their response to gravity.” Additionally, Bais and other UD researchers have shown the usage of a helper bacteria called B. subtilis UD1022 in promoting plant growth and fitness against pathogens or other stressors such as drought. They added the UD1022 to the microgravity simulation that on Earth can protect plants against Salmonella, thinking it might help the plants fend off Salmonella in microgravity. Instead, they found the bacterium actually failed to protect plants in space-like conditions, which could stem from the bacteria’s inability to trigger a biochemical response that would force a plant to close its stomata. “The failure of UD1022 to close stomata under simulated microgravity is both surprising and interesting and opens another can of worms,” Bais said. “I suspect the ability of UD1022 to negate the stomata closure under microgravity simulation may overwhelm the plant and make the plant and UD1022 unable to communicate with each other, helping Salmonella invade a plant.” To contact researchers from the team, visit the profiles for Bais or Kniel and click on the contact button.
Aston University AI project aims to make international health data sharing easier
Project to improve sharing data while complying with general data protection regulation (GDPR) guidelines Aston Institute of Photonic Technologies awarded almost £300k to work on European-wide project Will develop secure data sharing system to allow access to large sets of multi-source health data via tailor-made AI tools. Aston University is to explore the use of AI to improve sharing health data internationally. Dr Sergei Sokolovski of the University’s Aston Institute of Photonic Technologies has been awarded €317,500 to work on a European-wide project. Called BETTER (Better real-world health data distributed analytics research platform) the spans16 academic, medical and industrial partners. Although data-driven medicine is currently used to improve diagnosis, treatment and medical research ethical, legal and privacy issues can prevent sharing and centralising data for analysis. The research at Aston University’s involvement in the BETTER project aims to overcome these challenges so health data can be shared across national borders while fully complying with the general data protection regulation (GDPR) guidelines. Dr Sergei Sokolovski will lead the development of a secure data sharing system which will allow access to large sets of multi-source health data via tailor-made AI tools. Scientists and healthcare professionals will be able to compare, integrate and analyse data securely at a lower cost than current methods to improve people’s health. The BETTER project will focus on three health conditions; childhood learning disabilities, inherited degenerative retina diseases and autism, involving seven medical centres across the European Union and beyond. Dr Sergei Sokolovski said: “Data protection regulations prohibit data centralisation for analysis purposes because of privacy risks like the accidental disclosure of personal data to third parties. “Therefore, to enable health data sharing across national borders and to fully comply with GDPR guidelines this project proposes a robust decentralised infrastructure which will empower researchers, innovators and healthcare professionals to exploit the full potential of larger sets of multi-source health data. “As healthcare continues to evolve in an increasingly data-driven world projects like BETTER offer promising solutions to the challenges of health data sharing, research collaboration, and ultimately, improving the well-being of citizens worldwide. “The collaboration between multiple stakeholders, including medical centres, researchers, and innovators, highlights the importance of interdisciplinary efforts in addressing these complex issues.” The research will last 42 months. ENDS Better Real-World Health-Data Distributed Analytics Research Platform, Grant agreement 101136262 https://www.better-health-project.eu/ Research Universities taking part are: Aston University, Klinikum der Universitaet zu Koeln, Universiteit Maastricht, Universitat Politecnica de Valencia, Universitetet i Tromsoe, About Aston University Founded in 1895 and a university since 1966, Aston University is a long-established university led by its three main beneficiary groups – students, business and the professions, and the West Midlands region and wider society. Located in Birmingham at the heart of a vibrant city, the campus houses all the University’s academic, social and accommodation facilities for our students. Professor Aleks Subic is the Vice-Chancellor & Chief Executive. In 2022 Aston University was ranked in the top 25 of the Guardian University Guide, based on measures including entry standards, student satisfaction, research quality and graduate prospects. The Aston Business School MBA programme was ranked in the top 100 in the world in the Economist MBA 2021 ranking. For media inquiries in relation to this release, contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
Image shows how tiny water channels control how water enters and exits cells through their membranes The Aston Institute for Membrane Excellence (AIME) will be set up with a £10m grant from Research England AIME will be led by Professor Roslyn Bill from Biosciences and Professor Paul Topham from Chemical Engineering and Applied Chemistry The globally unique institute will use biomimetic polymer membranes for applications such as water purification and drug development Aston University will establish the Aston Institute for Membrane Excellence (AIME), a globally unique, cross-disciplinary institute to develop novel biomimetic membranes, after receiving a major grant of £10m from Research England. AIME will be led by Professor Roslyn Bill, from the School of Biosciences, with co-lead Professor Paul Topham from the department of Chemical Engineering and Applied Chemistry (CEAC). Membranes, both biological and synthetic, are hugely important in many sectors. For example, the world’s top ten selling human medicines all target proteins in biological membranes, while synthetic polymer membranes are used in the US$100bn/year water purification industry. The team behind AIME believes that the full potential of membranes will only be realised by an interdisciplinary group spanning biology, physics and chemistry that can investigate membranes holistically. Professor Bill, a European Research Council (ERC) Advanced grantee leads Aston Membrane Proteins and Lipids (AMPL) research centre of excellence that studies the structure and function of membrane proteins and associated lipids. Professor Topham leads Aston Polymer Research Group (APRG), which investigates the nanoscale behaviour of block copolymers (a type of polymer with a structure made of more than one type of polymer molecule) and polymer technologies for membranes. AMPL and APRG have already begun collaborative research and AIME will bring together the complementary expertise of both research clusters into one institute. AIME will initially comprise the eight researchers from AMPL and APRG. Alongside the co-leads Professor Bill and Professor Topham, will be Dr Alan Goddard, Professor Andrew Devitt, Professor Corinne Spickett, Dr Alice Rothnie, Dr Matt Derry and Dr Alfred Fernandez. It plans to recruit three further academics, six tenure-track research fellows, three postdoctoral research assistants (PDRAs), six PhD students, a research technician and a business development manager. Importantly, AIME will work with many existing Aston University colleagues to build a comprehensive research community focused on all aspects of membrane science. The new AIME team will focus on the development of bioinspired, highly selective polymer structures for applications in water purification and waste remediation, nanoparticles loaded with therapeutic molecules to treat disorders ranging from chronic wounds to neurological injuries, and the purification of individual membrane proteins with polymers to study them as drug targets. The vision is for AIME to become a ‘one-stop shop’ for interdisciplinary, translational membrane research through its facilities access and expertise, ideally located in the heart of the country. Professor Bill said: “The creation of AIME is ground-breaking. Together with Aston’s investment, E3 funding will deliver a step-change in scale and the rate at which we can grow capacity. We will address intractable scientific challenges in health, disease, and biotechnology, combining our world-class expertise in polymer chemistry and membrane biology to study membranes holistically. The excellence of our science, alongside recent growth in collaborative successes means we have a unique opportunity to deliver AIME’s ambitious and inclusive vision.” Professor Topham said: “We are really excited by this fantastic opportunity to work more closely with our expert colleagues in Biosciences to create advanced technology to address real world problems. From our side, we are interested in molecular engineering, where we control the molecular structure of new materials to manipulate their properties to do the things that we want! Moreover, we are passionate about a fully sustainable future for our planet, and this investment will enable us to develop technological solutions in a sustainable or ‘green’ way.” Professor Aleks Subic, Vice-Chancellor and Chief Executive of Aston University, says: “Our new Aston Institute for Membrane Excellence (AIME) will be a regional, national, and international research leader in membrane science, driving game-changing research and innovation that will produce a pipeline of high-quality research outcomes leading to socioeconomic impact, develop future global research leaders, create advanced tech spinout companies and high value-added jobs for Birmingham and the West Midlands region. Its establishment aligns perfectly with our 2030 strategy that positions Aston University as a leading university of science, technology and enterprise.” Steven Heales, Policy Manager (Innovation) at the West Midlands Combined Authority, said: “WMCA is delighted to see Research England back the Aston Institute for Membrane Excellence. This will enable Aston University’s excellent academics and research community to work closely with businesses to make advances in membrane technology and applications. “In 2023 the West Midlands Combined Authority agreed a Deeper Devolution Trailblazer Deal with Government, which included a new strategic innovation partnership with Government. Projects like AIME are exactly the kind of impact we expect this new partnership to generate, so watch this space.” Lisa Smith, chief executive of Midlands Mindforge, the patient capital investment company formed by eight Midlands research-intensive universities including Aston University, said: “This grant is an important vote of confidence in the Midlands scientific R&D ecosystem. AIME will play an important role in the future research of pioneering breakthroughs in membrane science and enable the world-leading research team at Aston University to develop solutions to real world problems. We look forward to closely working with the Institute and nurturing best-in-field research being undertaken at Aston out of the lab and into the wider society so it can make a positive impact”. Rob Valentine, regional director of Bruntwood SciTech, the UK’s leading developer of city-wide innovation ecosystems and specialist environments and a strategic partner in Birmingham Innovation Quarter, said: "As a proud supporter of the Aston Institute for Membrane Excellence (AIME), I am thrilled at the launch of this groundbreaking initiative. AIME exemplifies Aston University's commitment to advancing cutting-edge interdisciplinary research and further raises the profile of the region’s exemplary research capabilities and sector specialisms. AIME's vision of becoming a 'one-stop shop' for translational membrane research, strategically located at the heart of the country, aligns perfectly with our strategy at Bruntwood SciTech. We are committed to working with partners, including Aston University, to develop a globally significant innovation district at the heart of the UK where the brightest minds and most inspiring spaces will foster tomorrow’s innovation.” Membrane research at Aston University has also recently received two other grants. In November 2023, Professor Bill received £196,648 from the Biotechnology and Biological Sciences Research Council’s Pioneer Awards Scheme to understand how tiny membrane water channels in brain cells keep brains healthy. In December 2023, a team led by AIME team-member Dr Derry received £165,999 from the Engineering and Physical Sciences Research Council to develop biomimetic membranes for water purification. For more information about AIME, visit the webpage.
When it comes to New Year's resolutions, think small
By now, those of us who made New Year's resolutions are either off and running or off the rails. According to Philip Gable, professor in the Department of Psychological and Brain Sciences, a lack of commitment and setting the bar too high are among the reasons many people fail to stick with their resolutions and achieve their goals. “It's just this time of year when people feel like they should make a resolution, as opposed to other times in the year when it's less common but maybe more meaningful, like if you get a doctor's report and realize you need to change that aspect of your life," he said. When people set goals, they tend to feel very motivated for a few days and falsely assume they’re committed to their goal. But as soon as that motivation wears off, they give up. In order to be part of the 10% of people who keep their New Year’s resolutions, Gable said to break down big goals into small, achievable steps. “I think a lot of times with goals, people will commit to a very big goal and not realize the smaller steps they need to take to achieve that goal,” Gable said. “If we have too big of a goal, we get emotionally distressed when we can't do it, or we fail because we set too big of a goal. Or maybe we couldn't think through all of the elements required to meet that really big goal. So starting small gives us something achievable, and then that gives you a platform to go to the next thing.” To set up an interview with Gable, visit his profile and click on the contact button.
SME innovation through the lens of ancient myths - public lecture
Professor Nicholas Theodorakopoulos will explore the transformation in the perception of SMEs since the 1970s He will explain the significance of theory-driven design and delivery of interventions for building the capacity of SMEs to innovate The lecture will take place on Thursday 18 January 2024 at Aston Business School from 1800 hrs. Aston University entrepreneurship expert, Professor Nicholas Theodorakopoulos, will be giving his inaugural lecture at Aston Business School on Thursday 18 January 2024. In his talk SME Innovation, Theory-Driven Intervention, and Ancient Myths Professor Theodorakopoulos will explore the transformation in the perception of SMEs, from being viewed as an anachronism in the 1970s to becoming the driving engine of innovation and a prominent feature of public policy worldwide. Professor Theodorakopoulos will explore the significance of theory-driven design and delivery of interventions for building the capacity of SMEs to innovate and will explain that these are not just academic pursuits, but essential tools for developing replicable and impactful intervention programmes on a national and international scale. He will also present a compelling example of a successful intervention that he has run with colleagues for almost a decade in the West Midlands region. Professor Theodorakopoulos said: “The paradigm shift in SME perception necessitates a robust approach to fostering effective SME development ecosystems, not least through Research and Innovation policies. “A critical component of this policy domain lies in strengthening collaboration and knowledge exchange between universities and SMEs, often achieved through targeted interventions. “I look forward to drawing upon an ancient myth as a metaphor for the significance of knowing not just ‘what works’, but also ‘how it works’, in university-SME interventions.” The lecture is open to the public and free to attend in person or online. The in person event will be followed by a drinks reception. To book your place, click here.
Aston University invests £18 million to support doctoral research
Funding to recruit and nurture tomorrow’s researchers Investment will support University’s vision to be a leading university of science, technology and enterprise Investment in research at the interfaces of science, health and technology. Aston University is announcing investment of £18 million in doctoral research funding to recruit and nurture the research leaders of tomorrow. The investment supports the University’s vision to be a leading university of science, technology and enterprise. It will fund research at the interfaces of science, health, technology and enterprise, socio-economic transformations driven by digitalisation, and pressing economic, social and other challenges addressed by researchers in Aston University’s colleges and research institutes. Successful candidates will be recruited for the studentships on the basis of excellence and provided with the support they need to excel as doctoral researchers. They will drive forward their own research projects and make significant contributions to existing innovative research projects and teams. A range of support will be available, including full studentships covering the cost of UK fees and student stipend paid at rates equivalent to UKRI-funded studentships, as well as a fund for research expenses. Professor Phil Mizen, Associate Pro-Vice-Chancellor Researcher Development at Aston University, said: “This investment represents the University’s strategic commitment to supporting inclusive, entrepreneurial and translational research with a clear transformational impact so that the people, businesses and communities it serves can thrive economically, socially and culturally. “I am delighted that, through these studentships, we are able to provide more opportunities for doctoral researchers to gain essential skills and to foster excellence in research and innovation.”
Casting Light on the Dark Universe, Euclid's Mission Shows Promise
On December 7, 1968, the National Aeronautics and Space Administration (NASA) successfully launched the first functional space telescope into orbit. In the 55 years since, dozens of these crafts have embarked on missions of discovery, advancing and transforming our understanding of the cosmos. Among the latest is Euclid, a wide-angle space telescope developed by the European Space Agency (ESA). Equipped to chart portions of the universe that are not directly observable and currently shrouded in mystery, Euclid is working to generate a three-dimensional map unlike any other, surveying billions of galaxies out to 10 billion light-years. This past month, the first images from its journey were released. Joey Neilsen, PhD, is a world-renowned astrophysicist, a frequent collaborator with NASA and an assistant professor in Villanova University’s College of Liberal Arts and Sciences. From his perspective, Euclid’s early returns evidence its voyage’s incredible potential. “In Euclid’s first image of the Perseus cluster, the sheer number of galaxies is really astonishing,” said Dr. Neilsen. “We talk a lot about how the universe is mostly empty space—and it is!—but it’s also enormous, and it’s really stunning that there’s room for so many galaxies in just a small patch of sky. There are 1,000 galaxies here huddled together in this cluster and over 100,000 in the background. “I also note some pale purple patches in the image of NGC 6822. These are planetary nebulae, the layers of gas and dust blasted off by stars at the ends of their lives. It’s amazing to be able to see these so clearly in images that show the entire galaxy and its environment at the same time.” According to Dr. Neilsen, Euclid’s remarkable visuals are the product of a calculated tradeoff. The ESA craft sacrifices the fine resolution of images taken by other observatories, like NASA’s James Webb Space Telescope, to capture cosmic phenomena in greater breadth. By collecting these visuals, Euclid aims to spark breakthroughs on subjects as of yet understudied—breakthroughs that could benefit Dr. Neilsen’s field of research. “Euclid’s mission is to understand the evolution of the dark components of the universe: the invisible dark matter whose gravity holds large structures like galaxies and galaxy clusters together and the dark energy responsible for the accelerating expansion of the universe,” he explained. “Much of my research focuses on a different aspect of the dark universe (black holes), but there is a puzzle that might connect: observations of very distant galaxies show there were very massive black holes very early on. How did these behemoths grow so big so fast? If would be neat if Euclid helped us to better understand the early universe in a way that informed our understanding of the growth of black holes.” In tracking and investigating the dark entities that compose and mold the cosmos, Euclid could very well offer insights into the history and development of over 95% of all energy and matter—and perhaps into the very fabric of existence itself. It is reasonable to wonder whether, when its mission is complete in six years’ time, the telescope could provide us with answers to questions that have gone unaddressed for six billion years. “For me, the best-case scenario would be that Euclid would show clear evidence of something that’s hard to explain with our current models,” said Dr. Neilsen. “For example, right now, we have ‘Hubble tension,’ a discrepancy between measurements of the expansion of the universe from when it was young and from the current era… The moments when things don’t add up are the ones where we learn the most about how the universe works. So, I’ll keep my fingers crossed for a surprise and for more to learn over the next six billion years.”
Expert Perspective: Augusta University professor gives annual economic outlook for the region
For the 16th year, Augusta University’s Cree-Walker Chair and Professor of Economics in the Hull College of Business Simon Medcalfe, PhD, has given his analysis of the Augusta area economy. The biggest thing on the minds of many remains the possibility of a recession and the overall inflation nationwide. Medcalfe thinks it probably won’t look a lot different in 2024 as it did in 2023. If anything, there may be less of a chance of a recession. “I think the chances of recession have probably slipped a little. I think there’s less chance of a recession,” said Medcalfe. “Inflation is certainly still a concern. It’s running at 3.2%, which sounds kind of low, but because of the amount of inflation, we’ve had prices about 20% higher than two years ago, and it’s still a concern and still eating into people’s wages.” He indicated, looking at Google Trends and what people are searching, inflation is still a pretty high concern. As for the Augusta region, Medcalfe pointed out that Columbia County continues to see a population increase and will likely have the largest population in the area by the end of the decade on current trends. As you would expect, as the population grows, so too does the number of businesses. Looking at the different sectors of employment in the region, he said things haven’t really changed. The only sectors that have seen more than a 2% change in the share of total employment over the last 20 years are education and health services. Medcalfe also pointed out that the manufacturing industry has seen a sizable increase since 2014. He said it was the same time the Starbucks manufacturing facility arrived in South Augusta but didn’t say that was the exact reason for the increase, just a point of reference for the manufacturing industry increased ever since. “Manufacturing has showed a large increase over the last ten years or so, past post-COVID as well. So now manufacturing employment in the local area is at the highest it’s been since I’ve been here,” Medcafe said. Some research that Hull College is undertaking is the intersection of health care and business. He said it’s important to the economy in our region since Richmond, McDuffie and Burke counties all rank towards the bottom of county health rankings in Georgia. “One of the things we are looking at here in the business school and in the new School of Public Health is what are the factors that influence the population’s health but aren’t clinical? There’s a lot of things that impact people’s health. There’s socio-economic status, there’s the environment they live in, there’s education, there’s health behavior and all this kind of stuff. “About 25% of the research out of Hull College is now looking at health maps because it’s important. Not just the health of the population, but it then impacts the economy because we have a labor shortage and how much of that labor shortage is actually because some people can’t work,” said Medcalfe. Looking to know more? We can help. Simon Medcalfe, PhD, is a highly regarded economics expert in the Hull College of Business at Augusta University. Medcalfe is an expert that can talk on the national economy, as well as Georgia. He is available to speak with media – simply click on his icon now to arrange an interview today.
In Poland, the Debate Over Solidarity's Legacy Continues
On November 13, 2023, Poland’s parliament convened for the first time since a centrist-progressive coalition won a legislative majority, ending the eight-year rule of the right-wing Law and Justice party. The recent political shift has been heralded by some as the most significant since 1989, when the then-Soviet-controlled government allowed the country’s first elections in over four decades. That year, an anti-authoritarian movement called “Solidarity” seized all but one seat in the Senate and every contested seat in the Sejm (or lower chamber). A stunning rebuke for the Soviet regime, the landslide victory effectively signaled the end of Communism in Poland—and served as a harbinger of the Eastern Bloc’s collapse. Gerald Beyer, PhD, is a professor of Christian ethics in Villanova University’s College of Liberal Arts and Sciences, the instructor of the class “Solidarity and Peacebuilding in Central and Eastern Europe” and the author of Recovering Solidarity: Lessons from Poland’s Unfinished Revolution. He recently shared his thoughts concerning the parallels being drawn between 1989 and 2023, the complicated legacy of Poland’s anti-Communist struggle and what can be gleaned from studying and reconsidering the Solidarity movement. Q: As a new Polish government takes shape, how would you describe the current political situation in the country? Dr. Beyer: At the present moment, Poland finds itself at a major crossroads. Like the United States, the country is very divided, politically speaking. On the one hand, you have people who believe that Poland has turned away from the European Union (EU) to a troubling extent and backslid into authoritarianism under the Law and Justice party’s rule. So, you have a significant portion of Polish society who believe that this recent election [in October] was about protecting democracy and ensuring the future of democracy in the country. On the other hand, you have an equally significant portion of the population who think democracy has not been in peril—and that, in this year’s election, what’s at stake was a sense of Polish national values and national sovereignty. Q: Is there any credence to the new legislative majority’s claims that the Law and Justice party “overstepped” while in governance? DB: I think there’s reason to ask that question. The EU has sanctioned Poland during the present ruling party’s tenure for weakening the autonomy of the judicial system, and there has been concern over the ruling party exerting undue influence on state-based Television Poland (TVP). Poland, however, has a very vibrant free press—and has since 1989… I would contend that there’s been some backsliding on measures that would not score well on the democracy metrics, but I would not say that Poland has been existing under an authoritarian regime. Q: Do you consider this year’s election comparable to the election of 1989? DB: It’s certainly one of monumental significance. You may have noted the turnout of 74-plus percent. That’s historic for Poland, that massive turnout. At the same time, the overthrow of the Communist system in ’89 stands out as a unique and discrete moment in Polish history. So, there are ways that a comparison can be made, but there are ways in which I don’t believe it’s particularly apt. Q: What makes tying the events of 1989 and 2023 a complicated issue? DB: Whether or not 2023 is directly comparable to 1989 is a matter of perspective, and there are a number of different perspectives that exist in Poland today. Since the fall of Communism, there has been an ongoing conflict over Solidarity, its history and its legacy, and various political actors and parties have claimed their objectives are in concert with the values and principles of the movement. In this year’s election, the Law and Justice party’s candidates presented themselves as guarantors of freedom, which was at the heart of the Solidarity movement, by stressing their opposition to external forces like the EU. In addition, during their time in leadership, the party’s officials worked to institute a number of social welfare programs that were designed to help people economically, providing something akin to what Catholic social teaching calls a “family living wage.” So, they were actively trying to raise the standard of living in a way that was arguably analogous to Solidarity. On the other side of this equation, the election-winning opposition parties emphasized their status as defenders of democracy—once again, a core tenet of Solidarity. As we discussed, many members of that alliance and their supporters felt that the independent judiciary had been stifled by the Law and Justice-run government; they also voiced concerns about the free press. On both sides, there has existed and continues to exist a sense that they are the ones best suited, maybe even solely suited in the current political landscape, to carry on Solidarity’s legacy and to ensure Poland thrives. Herein lies the source of conflict. Q: Despite the ongoing debate over Solidarity’s legacy, are there any lessons from the movement’s history that might prove helpful today? DB: Sadly, much of Poland’s current political acrimony can be traced to the “war at the top” that emerged within Solidarity in the wake of 1989, when longstanding tensions within the movement manifested in political rivalries. Once united, anti-Communist organizers became adversaries in the years after the Soviet regime’s dissolution, laying the groundwork for the divisive rhetoric of the current day. Looking beyond what’s transpired over the past three decades, however, I think much can be learned from Solidarity in its early years and at its core. When the movement first took shape, its central aim was attaining a society characterized by unity among differences. And, to achieve this end, its leaders and supporters recognized the “necessity of dialogue,” a concept frequently invoked in Father Józef Tischner’s The Spirit of Solidarity. Given the stark divides that currently define Polish politics, I think these origins and these concepts should be revisited—and that it’s important to look at Solidarity not just as a political moniker, but as an objective and a virtue. Personally, I believe that people can change. And if they are reacquainted with the principles that inspired and guided their struggle for freedom and democracy, perhaps Poland’s elected officials can change for the better.